NPNico Pagano

Nico Pagano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nico Pagano has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Symptomatic ileal nodular lesion: a persisting diagnostic challenge

    by Andrea Saibanti, Marcello Di Martino, Nico Pagano, Matteo Donadon

    This case report details the diagnostic and therapeutic approach of a young male presenting with an ileal nodular lesion of uncertain aetiology whose final diagnosis was gastric heterotopia within a Meckel’s diverticulum. The case underscores the challenges of diagnosing ileal lesions due to the overlapping of clinical presentations of benign and malignant conditions. It highlights the importance of integrating advanced diagnostic tools and a multidisciplinary team approach to ensure accurate diagnosis and effective treatment.

  • Open Access

    Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms

    by Claudio Ricci, Riccardo Casadei, Giovanni Taffurelli, Elia Zani, Nico Pagano, Carlo Alberto Pacilio, Carlo Ingaldi, Selene Bogoni, Donatella Santini, Marina Migliori, et al.

    This study aimed to evaluate the accuracy of the risk factors proposed by Fukuoka guidelines in detecting malignancy of branch-duct intraductal papillary mucinous neoplasms. Diagnostic meta-analysis of cohort studies. A systematic literature search was conducted using MEDLINE, the Cochrane Library, Scopus, and the ISI-Web of Science databases to identify all studies published up to 2014. Twenty-five studies (2025 patients) were suitable for the meta-analysis. The "high risk stigmata" showed the highest pooled diagnostic odds ratio (jaundice, 6.3; positive citology, 5.5; mural nodules, 4.8) together with 2 "worrisome features" (thickened/enhancing walls, 4.2; duct dilatation, 4.0) and 1 "other parameters" (carbohydrate antigen 19-9 serum levels, 4.6). An "ideal risk factor" capable of recognizing all malignant branch-duct intraductal papillary mucinous neoplasms was not identified and some "dismal areas" remain. However, "high risk stigmata" were strongly related to malignancy, mainly enhancing mural nodules. Among the "worrisome features," duct dilatation and thickened/enhancing walls were underestimated, and their diagnostic performance was similar to those of "high risk stigmata." The carbohydrate antigen 19-9 serum level should be added to the Fukuoka algorithm because this value could help in carrying out correct management.